Unique ID issued by UMIN | UMIN000005061 |
---|---|
Receipt number | R000006004 |
Scientific Title | A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors. |
Date of disclosure of the study information | 2011/02/18 |
Last modified on | 2018/08/17 19:14:47 |
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
Japan |
lung tumor
Pneumology | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of SBRT with real-time tumor tracking using CyberKnife and Monte Carlo argorythm for lung tumors. (phase I study)
Safety
Exploratory
Phase I
incidence of Grade 3 or higher radiation pneumonitis within 180 days after stereotactic body radiotherapy
Overall survival, Progression-free survival, local progression-free survival, 3-year survival, 3 year local progression free survival, Event-free survival, 3 year local control rate, pattern of progression, Grade 2 or higher radiation pneumonitis, adverse event, severe adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Stereotactic body radiotherapy using real-time tumor tracking with 45 or 50 or 55 Gy delivered in 4 fractions, once a day, twice a week.
20 | years-old | <= |
Not applicable |
Male and Female
1.Histologically or transbronchoscopic cytologically confirmed Primary or metastatic lung cancer diagnosed by images
2.cT1aN0M0,cT1bN0M0,cT2aN0M0(UICC7th) or lung oligometastasis within 5 cm diagnosed by images within 28 days
3.Dose constraints of the organs at risk seem to be limited within range
4.no previous radiotherapy around the lesion
5.20 years old or higher
6.ECOG-PS=0-2
7.Respiratory function (<=28 days)
(1)PaO2>=60 torr
(2)FEV1.0>=700 ml
8.Only tracking irradiation
9.Written informed consent
1.active infection needed therapy
2.fever of 38.0 degrees centigrade or higher
3.pregnancy
4.psychiatric disorder
5.steroid administration
6.Patients who are considered to be inappropriate for this study by physicians
35
1st name | |
Middle name | |
Last name | Yuta Shibamoto |
Nagoya City University Graduate School of Medical Sciences
Radiology
1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan
052-853-8276
yshiba@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Hiromitsu Iwata |
Nagoya City West Medical Center
Nagoya Proton Therapy Center
1-1-1, Hirate-cho, Kita-ku, Nagoya
052-991-8588
cyber@syck.jp
Department of Radiology, Nagoya City University Graduate School of Medical Sciences
none
Self funding
Shinryoku neurosurgical clinic, Yokohama CyberKnife Center
NO
新緑脳神経外科横浜サイバーナイフセンター(神奈川県)
2011 | Year | 02 | Month | 18 | Day |
http://www.syck.jp/medical_care/cyberknife5.html
Published
Main results already published
2011 | Year | 02 | Month | 04 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 02 | Month | 10 | Day |
2018 | Year | 08 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006004